FIELD: medicine.
SUBSTANCE: present invention refers to medicine, namely to oncology, and concerns potentiating cytostatic agent activity. In addition to the cytostatic preparation cisplatin, mycotoxin T-2 is administered in sub-toxic doses.
EFFECT: such combined introduction under experimental conditions provides tumour growth inhibition and reduced metastasis due to synergetic action of said preparations.
1 cl, 2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SPECIFIC COMBINED THERAPY OF MALIGNANT TUMOURS WITH CYTOSTATIC AGENT AND ITS MODIFYING AGENT | 2015 |
|
RU2571551C1 |
| PEPTIDE, POSSESSING ANTI-TUMOR AND ANTI-METASTATIC ACTIVITY, AND FINISHED DOSAGE FORM BASED THEREON | 2018 |
|
RU2682039C1 |
| PHARMACEUTICAL COMPOSITION BASED ON PALLADIUM COMPOUND | 2015 |
|
RU2613305C2 |
| METHOD OF COMBINED CONSERVATIVE EFFECT ON MALIGNANT TUMOURS | 2008 |
|
RU2392935C1 |
| METHOD FOR ACHIEVING ANTIMETASTATIC EFFECT IN EXPERIMENT | 2017 |
|
RU2661704C1 |
| METHOD OF COMBINED THERAPY FOR CONNECTIVE TISSUE SARCOMA M-1 IN RATS USING A CONJUGATE OF DIPROPOXYBACTERIOPURPURIN WITH DOXORUBICIN | 2023 |
|
RU2808909C1 |
| COMBINATION OF DEHYDROXYMETHYL EPOXYQUINOMYCIN (DHMEQ) AND CYTOSTATICS FOR TREATING OVARIAN CANCER | 2018 |
|
RU2704020C1 |
| IMMUNOSTIMULATING PREPARATION POSSESSING ANTI-TUMOR ACTIVITY | 2015 |
|
RU2597837C1 |
| METHOD OF SUPPRESSION OF TUMOR GROWTH | 1996 |
|
RU2114623C1 |
| REMEDY WITH ANTI-TUMOR EFFECT FOR TREATMENT OF ONCOLOGICAL DISEASES | 2018 |
|
RU2761429C2 |
